| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POMALIDOMIDE | 210164 | 001 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 1MG | No | No | 2024/06/11 | 2024/06/11 | APOTEX | Prescription |
| POMALIDOMIDE | 210164 | 002 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 2MG | No | No | 2024/06/11 | 2024/06/11 | APOTEX | Prescription |
| POMALIDOMIDE | 210164 | 003 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 3MG | No | No | 2024/06/11 | 2024/06/11 | APOTEX | Prescription |
| POMALIDOMIDE | 210164 | 004 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 4MG | No | No | 2024/06/11 | 2024/06/11 | APOTEX | Prescription |
| POMALIDOMIDE | 210236 | 001 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 1MG | No | No | 2024/09/26 | 2024/09/26 | HETERO LABS LTD V | Prescription |
| POMALIDOMIDE | 210236 | 002 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 2MG | No | No | 2024/09/26 | 2024/09/26 | HETERO LABS LTD V | Prescription |
| POMALIDOMIDE | 210236 | 003 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 3MG | No | No | 2024/09/26 | 2024/09/26 | HETERO LABS LTD V | Prescription |
| POMALIDOMIDE | 210236 | 004 | ANDA | POMALIDOMIDE | CAPSULE;ORAL | 4MG | No | No | 2024/09/26 | 2024/09/26 | HETERO LABS LTD V | Prescription |